epilepsy: A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
212 |
4. Check minimum number of eventsNone |
212 |
5. Include endpointsNone |
212 |
6. Filter based on genotype QC (FinnGen only) |
212 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G405
- Name in latin
- Ictus epileptici ex usu alcohol
Similar endpoints
↥List of similar endpoints to
Epileptic seizures related to alcohol
based on the number of shared cases.
Similar with more cases:
- Epilepsy
- Alcohol use disorder, Swedish definition
- Alcohol related diseases, tilastokeskus definition
- Alcohol related diseases and deaths, all endpoints
- Episodal and paroxysmal disorders
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3694 | 714 | 2952 |
| Only index persons | 2804 | 567 | 2237 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.02 | 0.08 |
| Only index persons | 0.07 | 0.02 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 51.19 | 51.05 | 51.18 |
| Only index persons | 51.40 | 51.11 | 51.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 212 | 44 | 168 |
| Unadjusted period prevalence (%) | 0.06 | 0.01 | 0.07 |
| Median age at first event (years) | 51.72 | 47.35 | 52.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 191
- Matched controls
- 1908
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
276.4
191
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
86.4
119.9
133
49
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
45.5
103.0
138
103
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
118.7
66.5
69
9
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
35.3
55.2
72
32
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
27.7
46.0
64
34
G40.9
ICD-10 Finland
Epilepsy, unspecified
31.4
45.6
61
28
P15
ICPC
Chronic alcohol abuse
18.0
36.0
58
45
F10.25
ICD-10 Finland
Alcohol dependence continuous use
24.0
34.1
49
27
AA1AD
NOMESCO Finland
CT of head and brain
7.4
34.1
105
270
F10.20
ICD-10 Finland
Alcohol dependence currently independent
25.2
34.0
48
25
N07BB01
ATC
disulfiram; oral
13.4
30.7
56
57
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
27.1
29.8
41
19
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
32.3
29.8
39
15
N03AX14
ATC
levetiracetam; systemic
25.7
29.4
41
20
F10.09
ICD-10 Finland
Alcohol intoxication UNS
20.0
29.0
44
28
N03AG01
ATC
valproic acid; systemic, rectal
13.2
28.9
53
54
F10.24
ICD-10 Finland
Alcohol depence active use
29.3
28.3
38
16
N03AF01
ATC
carbamazepine; oral, rectal
14.9
27.9
48
42
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
27.5
27.9
38
17
N05BA01
ATC
diazepam; systemic, rectal
8.6
26.9
64
105
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
31.5
25.9
34
13
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
5.4
25.2
102
335
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
54.3
24.1
28
6
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
22.7
23.6
34
18
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
23.2
23.1
33
17
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
52.0
23.0
27
6
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
26.1
22.6
31
14
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
91.1
22.2
24
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
39.0
21.8
27
8
T36
ICD-10 Finland
Poisoning by systemic antibiotics
12.6
21.4
39
38
N05BA02
ATC
chlordiazepoxide; systemic
18.1
20.6
32
21
G41.9
ICD-10 Finland
Status epilepticus, unspecified
117.3
20.0
21
*
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
25.9
18.3
25
11
N03AF02
ATC
oxcarbazepine; oral
17.0
17.8
28
19
W19
ICD-10 Finland
Unspecified fall
7.7
17.8
43
69
P16
ICPC
Acute alcohol abuse
19.8
17.5
26
15
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.0
17.3
63
170
S06.0
ICD-10 Finland
Concussion
7.4
17.2
43
72
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
69.9
17.1
19
*
S01.0
ICD-10 Finland
Open wound of scalp
6.7
17.1
46
86
N06AX11
ATC
mirtazapine; oral
3.9
16.7
91
359
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
14.1
16.5
28
23
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.6
16.1
30
30
N03AB02
ATC
phenytoin; systemic
26.0
15.5
21
9
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
11.9
15.3
28
27
G40
ICD-10 Finland
Epilepsy
46.4
14.4
17
*
N05CF01
ATC
zopiclone; oral
3.5
14.2
86
358
N05AB01
ATC
dixyrazine; systemic
24.7
13.2
18
8
Z72.1
ICD-10 Finland
Alcohol use
24.7
13.2
18
8
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
15.6
13.1
21
15
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
15.8
12.6
20
14
A98
ICPC
Health maint/preventive medicine
0.3
12.4
131
1705
K70.1
ICD-10 Finland
Alcoholic hepatitis
32.3
11.8
15
5
N05AH04
ATC
quetiapine; oral
3.9
11.7
54
176
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
11.6
11
*
G72.8
ICD-10 Finland
Other specified myopathies
26.9
11.3
15
6
N05CD07
ATC
temazepam; oral
4.8
11.3
39
96
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
14.1
10.9
18
14
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
30.0
10.9
14
5
N06AB04
ATC
citalopram; systemic
3.4
10.8
61
232
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
116.1
10.5
11
*
R41.0
ICD-10 Finland
Disorientation, unspecified
12.3
10.3
18
16
N05AA02
ATC
levomepromazine; systemic
6.7
10.3
26
44
X59
ICD-10 Finland
Exposure to unspecified factor
3.3
10.2
61
240
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
16.1
9.7
15
10
S06.3
ICD-10 Finland
Focal brain injury
16.1
9.7
15
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
9.7
55
207
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
31.8
9.5
12
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
10.3
9.5
18
19
R53
ICD-10 Finland
Malaise and fatigue
3.5
9.5
47
161
V03AA01
ATC
NA
8.1
9.2
20
27
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
19.8
9.1
13
7
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
13.4
9.0
15
12
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
10.2
9.0
17
18
C07AA05
ATC
propranolol; systemic
3.4
8.8
47
168
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
10.8
8.7
16
16
E87.6
ICD-10 Finland
Hypokalaemia
8.0
8.7
19
26
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.7
8.7
39
123
T90.5
ICD-10 Finland
Sequelae of intracranial injury
21.2
8.6
12
6
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
29.0
8.6
11
*
G40.50
ICD-10 Finland
Epilepsia partialis continua [Kozhevnikof]
+∞
8.4
8
*
S42.2
ICD-10 Finland
Fracture of upper end of humerus
9.6
8.2
16
18
WX730
NOMESCO Finland
Conventional respirator
11.5
7.9
14
13
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
7.9
58
256
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
46.9
7.8
9
*
K29.2
ICD-10 Finland
Alcoholic gastritis
46.9
7.8
9
*
183
Kela drug reimbursment
Lamotrigin and topiramate
19.3
7.7
11
6
F05.9
ICD-10 Finland
Delirium, unspecified
10.7
7.7
14
14
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
26.2
7.7
10
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
83.2
7.5
8
*
N07
ICPC
Convulsion/seizure
83.2
7.5
8
*
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
83.2
7.5
8
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
7.8
7.4
16
22
G40.89
ICD-10 Finland
Other epilepsy
+∞
7.3
7
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
7.3
7
*
N88
ICPC
Epilepsy
31.3
7.2
9
*
N06AX16
ATC
venlafaxine; oral
3.5
7.2
34
112
W10
ICD-10 Finland
Fall on and from stairs and steps
6.3
7.1
18
31
N06AB03
ATC
fluoxetine; oral
3.7
7.0
31
96
N05BA04
ATC
oxazepam; oral
2.7
7.0
56
258
K70.0
ICD-10 Finland
Alcoholic fatty liver
17.5
6.8
10
6
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.4
6.8
24
61
C03CA01
ATC
furosemide; systemic
2.5
6.7
57
273
R55
ICD-10 Finland
Syncope and collapse
3.6
6.5
29
91
N05AD03
ATC
melperone; systemic
15.0
6.5
10
7
SPAT1227
SPAT
Substance abuse rehabilitation
15.0
6.5
10
7
G40.59
ICD-10 Finland
Other special epileptic syndromes
72.2
6.5
7
*
N03AE01
ATC
clonazepam; systemic
5.2
6.4
19
40
R40.2
ICD-10 Finland
Coma, unspecified
9.8
6.4
12
13
SPAT1265
SPAT
Breathalyser
18.8
6.3
9
5
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
13.1
6.2
10
8
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
9.1
6.2
12
14
S00.0
ICD-10 Finland
Superficial injury of scalp
10.5
6.1
11
11
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
6.1
33
118
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
76
272
3.80
18.13
4.4
2.0
%
2.0
1.6
1.97
68
243
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
132
1789
0.31
14.78
4.4
4.5
mmol/l
1.4
1.4
0.84
125
1670
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
133
1794
0.31
14.64
4.8
4.6
mmol/l
4.5
4.6
0.32
127
1684
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
126
1743
0.32
14.34
4.3
4.1
mmol/l
1.4
1.3
0.30
117
1624
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
139
1819
0.32
13.39
5.1
5.0
mmol/l
2.5
2.8
2.12
132
1698
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
311
2.99
12.00
3.6
3.7
mmol/l
0.7
0.8
5.20
66
294
(3003396) Base excess in Arterial blood by calculation
57
219
3.19
11.60
8.4
8.4
mmol/l
1.6
1.1
0.41
44
172
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
104
566
2.64
10.92
5.1
2.8
u/l
58.9
57.2
0.14
98
529
(3011288) Drugs identified in Urine by Screen method
21
41
5.58
10.55
15.2
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
135
1745
0.38
9.96
5.1
4.5
mmol/l
6.2
6.0
0.51
126
1615
(3019309) Folate [Moles/volume] in Red Blood Cells
61
276
2.70
9.02
1.8
1.6
nmol/l
1077.3
1237.4
0.74
52
215
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
52
4.37
8.01
4.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
134
1693
0.43
7.48
24.2
13.0
ml/min/173m2
89.0
83.3
1.70
108
1405
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
32
113
3.16
7.33
10.2
10.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
85
486
2.25
7.32
4.9
4.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
60
298
2.41
7.14
2.0
2.1
s
29.5
29.8
0.23
55
292
(3020564) Creatinine [Moles/volume] in Serum or Plasma
166
1915
0.39
6.87
31.7
16.8
umol/l
77.7
81.8
0.42
166
1915
(3000764) Benzodiazepines [Presence] in Urine
22
69
3.44
6.06
4.0
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
116
789
2.04
6.04
12.0
7.9
mmol/l
1.2
1.2
3.56
100
680
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
41
184
2.52
6.00
1.8
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
70
3.39
5.93
4.0
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
70
3.39
5.93
3.9
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
65
3.48
5.90
4.2
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
61
329
2.20
5.87
3.1
2.7
mosm/kgh2o
505.7
600.0
2.08
55
281
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
186
2.49
5.86
1.8
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
77
457
2.08
5.78
4.9
4.4
ph
7.4
7.4
0.33
15
82
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
108
724
2.00
5.78
9.5
6.6
mmol/l
1.2
1.2
5.07
103
667
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
313
2.17
5.55
7.1
3.8
ng/l
472.2
290.5
0.18
51
242
(3028707) Methadone [Presence] in Urine by Screen method
13
30
4.55
5.37
2.7
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
97
640
1.95
5.31
5.3
3.9
u/l
47.3
34.2
2.24
91
610
(3027944) Amphetamines [Presence] in Urine
21
70
3.22
5.27
4.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
31
130
2.62
5.18
9.3
4.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
104
717
1.88
4.87
9.0
8.3
inr
1.1
1.2
1.15
28
194
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
8
7
11.81
4.82
2.9
2.3
umol/l
39.9
61.0
—
8
7
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
633
0.43
4.79
2.4
2.8
ug/l
0.5
0.7
1.19
22
402
(1761868) Lipid panel - Serum or Plasma
40
711
0.46
4.73
4.0
2.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
165
1871
0.47
4.65
27.8
13.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
65
391
1.96
4.55
3.4
2.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
259
2.10
4.52
2.0
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
103
725
1.82
4.38
7.0
5.7
g/l
33.3
35.7
3.16
96
687
(3000991) Gas panel - Venous blood
32
148
2.37
4.36
9.1
8.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
155
2.34
4.34
7.6
3.8
mmol/l
1.3
2.0
0.50
27
122
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
141
1670
0.54
4.20
6.1
5.7
mmol/mol
40.0
40.1
0.05
130
1587
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
215
2.12
4.14
3.5
3.4
umol/l
10.3
9.9
0.05
36
191
(4198724)
7
7
10.29
4.04
5.6
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
867
0.53
4.02
4.2
4.1
%
22.2
21.5
0.14
28
391
(3019150) Specific gravity of Urine by Refractometry
58
352
1.89
3.89
4.4
3.4
kg/l
1.0
1.0
3.25
14
42
(3012544) pH of Venous blood
32
160
2.18
3.63
7.7
4.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
39
640
0.52
3.37
1.8
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
185
0.25
3.30
2.6
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
129
1024
1.66
3.19
5.4
3.6
e6/l
11902.2
49.3
—
5
19
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
127
2.19
3.13
1.8
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
131
1048
1.65
3.11
10.0
5.0
mmol/l
6.7
6.8
0.13
124
991
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
90
2.35
2.90
5.0
2.5
%
1.9
1.3
0.92
20
90
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
130
1528
0.61
2.88
4.3
4.0
mu/l
1.9
2.0
0.51
121
1394
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
74
0.00
2.83
0.0
1.9
—
249.7
—
0
68
(3009542) Hematocrit [Volume Fraction] of Blood
144
1649
0.60
2.80
30.5
15.0
%
37.4
41.2
3.22
83
1242
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
57
377
1.70
2.79
2.8
1.9
mg/l
2.5
3.2
1.89
48
336
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
44
2.83
2.59
1.3
1.6
ug/g
138.7
286.5
—
6
28
(3012501) Base excess in Blood by calculation
10
33
3.13
2.56
7.4
3.8
mmol/l
1.7
2.3
—
5
21
(3013290) Carbon dioxide [Partial pressure] in Blood
10
33
3.13
2.56
7.4
3.8
kpa
4.8
5.0
—
10
33
(3027315) Oxygen [Partial pressure] in Blood
10
33
3.13
2.56
7.4
3.8
kpa
8.9
8.4
—
10
33
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
99
2.13
2.35
1.5
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
115
2.02
2.25
3.0
2.8
mmol/l
0.9
1.6
0.27
14
87
(3009343) pH of Capillary blood
22
120
1.93
2.02
3.1
2.8
ph
7.4
7.4
—
6
13
(3002582) Erythrocytes [#/volume] in Urine
69
515
1.50
1.98
4.2
2.9
e6/l
44.1
184.3
0.59
56
408
(21494755) Public health laboratory ask at order entry panel
10
222
0.42
1.97
1.4
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
100
806
1.46
1.95
4.5
3.2
estimate
0.0
0.0
0.00
17
147
(3021901) Oxygen saturation in Capillary blood
8
28
2.93
1.88
2.4
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
35
2.64
1.82
7.2
3.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
34
220
1.65
1.79
1.7
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
88
1069
0.70
1.79
3.0
2.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
0
46
0.00
1.73
0.0
1.1
—
7.1
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
162
1759
0.66
1.66
28.0
14.2
mg/l
26.5
24.0
0.48
142
1405
(3017446) Testosterone [Moles/volume] in Serum or Plasma
13
245
0.50
1.65
1.2
2.3
nmol/l
15.5
13.9
0.29
13
226
(3020891) Body temperature
14
70
2.07
1.63
8.1
3.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
26
2.75
1.59
1.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
98
811
1.39
1.55
5.1
4.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
180
1.64
1.52
5.9
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
73
576
1.41
1.52
5.0
3.4
e6/l
44.4
158.5
0.88
58
426
(3029937) Albumin [Presence] in Urine by Test strip
57
432
1.44
1.48
5.2
3.4
estimate
0.0
0.0
0.50
17
139
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
616
1.39
1.48
4.3
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
23
2.65
1.37
5.5
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
227
1.54
1.37
4.1
2.4
%
27.6
22.3
0.77
25
201
(3044640) Blood type and Crossmatch panel - Blood
68
540
1.38
1.35
2.9
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
202
0.52
1.31
1.7
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
97
819
1.34
1.29
4.6
3.2
estimate
0.0
0.0
0.00
18
135
(3041354) Potassium [Moles/volume] in Venous blood
6
25
2.44
1.25
5.3
3.8
mmol/l
4.1
4.1
—
6
25
(3035285) Chloride [Moles/volume] in Venous blood
6
25
2.44
1.25
5.3
3.8
mmol/l
101.0
104.6
—
6
25
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
25
2.44
1.25
5.3
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
59
463
1.38
1.25
4.5
2.9
e6/l
0.6
0.5
0.15
50
352
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
78
640
1.35
1.25
5.0
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
128
1130
1.34
1.24
4.4
3.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
37
2.21
1.23
1.1
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
218
1.49
1.18
1.3
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
56
440
1.37
1.17
4.5
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
48
368
1.39
1.16
4.1
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
39
289
1.43
1.14
3.6
2.6
e6/l
2.0
1.0
0.76
23
173
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
40
2.04
1.13
1.4
2.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
37
487
0.71
1.10
1.4
1.3
—
—
—
0
0
(44790048)
5
21
2.41
1.09
1.2
1.8
—
—
—
0
0
(44790049)
5
21
2.41
1.09
1.2
1.8
—
—
—
0
0
(44806118)
5
21
2.41
1.09
1.2
1.8
—
—
—
0
0
(44790047)
5
21
2.41
1.09
1.2
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
147
0.53
1.08
1.3
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
52
1.97
1.08
1.5
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
94
806
1.30
1.08
6.0
4.4
estimate
0.0
0.0
0.00
19
150
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
33
2.16
1.06
1.1
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
107
1.64
1.03
2.1
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
35
2.03
1.01
1.6
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
54
1.89
0.98
2.7
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
31
0.00
0.97
0.0
1.7
—
4.7
—
0
11
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
210
1.44
0.97
1.9
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
81
689
1.28
0.97
6.1
3.6
ng/l
34.6
38.3
0.10
61
486
(3022313) Gas panel - Capillary blood
15
94
1.64
0.93
3.1
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
42
1.94
0.89
3.9
3.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
43
1.89
0.88
1.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
44
1.85
0.87
1.3
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
44
1.85
0.87
1.3
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
112
0.52
0.86
1.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
39
489
0.75
0.84
2.0
1.7
mmol/l
1.4
1.4
0.20
33
415
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
141
1298
1.26
0.82
8.2
3.3
u/l
147.4
56.0
3.93
136
1237
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
47
1.73
0.81
1.8
2.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.0
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
1.0
—
0
9
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
27
0.00
0.78
0.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
27
0.00
0.78
0.0
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
1.3
—
48.8
—
0
8
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
253
0.68
0.78
1.3
1.2
iu/ml
26.1
45.7
—
7
81
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.0
—
22.7
—
0
6
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
515
1.26
0.76
2.7
4.2
mmol/l
2.3
2.3
0.38
49
456
(3000494) Fungus identified in Specimen by Culture
29
222
1.35
0.73
1.6
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
25
2.02
0.73
2.4
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
49
406
1.27
0.71
2.5
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
50
416
1.26
0.70
4.4
7.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
115
1252
0.82
0.70
3.5
3.9
mm/h
18.6
11.0
3.97
108
1163
(3000492) Spirometry study
14
202
0.67
0.69
1.3
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.2
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
94
0.52
0.68
1.2
1.2
u/ml
96.6
180.6
—
5
80
(3025941) Bacteria identified in Stool by Culture
13
86
1.55
0.68
1.6
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
104
1.48
0.64
2.5
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
73
641
1.21
0.63
3.8
2.5
ug/l
238.2
175.8
1.08
68
597
(4035726)
10
151
0.65
0.62
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
50
1.62
0.62
1.3
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
30
1.68
0.62
3.6
3.3
e9/l
4.5
4.4
—
5
30
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
30
1.68
0.62
1.6
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
51
1.59
0.61
1.5
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
44
367
1.25
0.61
1.8
1.8
mg/l
1.2
1.4
0.18
34
292
(3021589) Normoblasts [#/volume] in Blood
68
770
0.83
0.60
14.6
10.3
e9/l
0.0
0.0
0.53
55
635
(3000093) Morphology [Interpretation] in Blood Narrative
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
22
0.00
0.59
0.0
2.4
—
1.0
—
0
11
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(4268621)
0
22
0.00
0.59
0.0
2.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
35
1.73
0.58
1.2
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
34
277
1.27
0.57
3.7
2.7
e6/l
1.7
1.1
0.43
19
162
(4034850)
10
66
1.54
0.53
12.1
10.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
35
290
1.25
0.52
2.7
2.0
—
—
—
0
0
(3013512) EKG study
45
522
0.82
0.51
5.2
3.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
320
0.79
0.50
1.2
1.4
g/l
4.0
2.7
1.49
17
209
(36660697) Celiac disease serology panel - Serum
7
109
0.63
0.50
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
16
210
0.74
0.49
1.1
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
46
1.54
0.49
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
46
1.54
0.49
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
46
1.54
0.49
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
46
1.54
0.49
2.4
3.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
111
1.38
0.48
1.9
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
66
591
1.17
0.45
4.5
6.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
16
122
1.34
0.44
1.7
2.3
e9/l
3.8
3.9
0.10
16
92
(3044290) Cell count panel - Cerebral spinal fluid
5
31
1.63
0.43
1.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
32
1.58
0.42
3.6
3.4
%
62.2
55.1
—
5
32
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
33
1.53
0.41
1.2
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
4.1
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
0.2
—
0
11
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
52
461
1.17
0.40
4.6
2.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
203
0.77
0.40
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
257
0.80
0.40
1.7
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
111
0.71
0.38
1.0
1.3
—
32.7
—
0
9
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
27
226
1.22
0.38
1.9
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
37
1.36
0.37
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
37
1.36
0.37
2.4
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
135
1.28
0.36
6.6
3.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
79
0.62
0.36
1.4
2.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
17
210
0.79
0.35
4.2
4.9
u/l
219.8
260.4
1.31
17
201
(3006504) Eosinophils/100 leukocytes in Blood
88
819
1.13
0.34
4.8
6.3
%
3.1
2.9
0.29
82
767
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
31
267
1.19
0.34
2.1
3.6
mmol/l
2.5
2.4
0.24
25
231
(3022096) Basophils/100 leukocytes in Blood
86
800
1.13
0.34
4.8
6.3
%
0.7
0.7
0.16
80
750
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
287
1.18
0.32
2.0
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
52
1.36
0.31
4.1
5.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
88
823
1.12
0.31
5.1
6.6
%
9.4
9.0
0.51
82
776
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
70
649
1.12
0.29
2.5
1.9
pmol/l
88.5
94.9
0.48
44
361
(3009508) Creatinine [Moles/volume] in Urine
61
562
1.12
0.28
3.6
3.0
mmol/l
7.6
8.8
1.00
48
477
(3019225) pH of Specimen
13
159
0.81
0.25
4.6
4.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
48
523
0.89
0.25
3.2
3.2
mg/l
98.4
200.4
0.32
28
350
(3049717) Cytology report of Urine Cyto stain
9
77
1.18
0.24
3.0
2.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
182
1.17
0.22
3.0
5.3
ug/l
18.7
78.2
0.69
21
156
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
145
0.82
0.21
2.0
2.1
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
1.0
—
0
6
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.1
—
891.5
—
0
11
(3025130) Human papilloma virus identified in Specimen
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
89
847
1.09
0.21
5.0
6.4
%
25.9
27.5
0.70
84
797
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
0
13
0.00
0.21
0.0
2.3
—
501.2
—
0
5
(3010503) CD19 cells [#/volume] in Blood
0
13
0.00
0.21
0.0
1.6
—
0.2
—
0
13
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
(4024509)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
4.8
—
0
5
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
14
0.00
0.20
0.0
2.9
—
14.3
—
0
8
(3017569) Oxygen content in Arterial blood
0
14
0.00
0.20
0.0
6.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
14
0.00
0.20
0.0
2.1
—
5.4
—
0
14
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
122
0.81
0.19
1.9
2.4
—
16.9
—
0
6
(3013115) Eosinophils [#/volume] in Blood
94
900
1.08
0.19
5.4
6.5
e9/l
0.2
0.2
0.18
84
795
(3013650) Neutrophils [#/volume] in Blood by Automated count
104
1000
1.08
0.19
8.4
11.0
e9/l
4.3
4.1
0.25
93
875
(3019198) Lymphocytes [#/volume] in Blood
94
901
1.08
0.18
4.7
6.3
e9/l
1.8
1.9
0.17
81
795
(3018010) Neutrophils/100 leukocytes in Blood
87
832
1.08
0.18
4.9
6.2
%
55.7
57.3
0.59
82
786
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
48
513
0.92
0.17
2.5
3.0
ng/l
2073.0
998.0
0.97
42
430
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
130
0.84
0.16
2.0
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
123
1263
0.94
0.15
4.4
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
115
0.86
0.11
1.2
2.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
90
877
1.05
0.09
4.7
6.3
e9/l
0.7
0.6
1.02
77
756
(3020682) Albumin/Creatinine [Ratio] in Urine
54
561
0.95
0.09
3.9
3.9
mg/mmol
21.4
10.7
0.33
34
376
(40760892) CBC W Ordered Manual Differential panel - Blood
38
399
0.94
0.09
4.2
5.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
61
0.82
0.08
1.4
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
64
0.78
0.08
1.2
3.0
—
1.3
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
74
1.08
0.07
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
47
488
0.95
0.07
2.5
2.7
umol/l
350.9
5417.2
1.56
40
425
(3006315) Basophils [#/volume] in Blood
90
880
1.04
0.07
4.7
6.3
e9/l
0.0
0.0
0.35
77
764
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
82
0.85
0.07
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
86
1.05
0.07
4.4
3.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
130
1.08
0.04
4.4
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
210
1.05
0.04
15.8
7.8
—
—
—
0
0
(4010399)
12
129
0.93
0.03
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
22
212
1.04
0.02
1.4
1.4
titre
672.0
394.9
—
5
47
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
137
0.95
0.01
1.4
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
134
0.97
0.00
2.2
2.6
ml/min/173m2
57.8
67.7
—
6
59
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
4.5
—
131.2
—
0
8
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
7.0
—
26.0
—
0
8
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
59
0.84
0.00
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
162.4
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1569.2
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
49
1.02
0.00
1.8
1.5
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
32
320
1.00
0.00
1.2
1.2
u/ml
0.8
1.0
—
10
96
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
56
0.89
0.00
1.4
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
53
0.94
0.00
1.4
1.3
—
5.3
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
9.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
24.5
—
0
5
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
29.8
—
0
6
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.8
—
194.3
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
59
0.84
0.00
1.4
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.8
—
7.0
—
0
5
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
217.0
—
0
9
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
73
0.96
0.00
3.4
3.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
3.5
—
0
6
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
9.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
112.1
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint EPISEIZALCO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| EPISEIZALCO | 9.296 [7.52, 11.49] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.38 |
During the follow-up period (1.1.1998 — 31.12.2019), 231 out of 611 females with EPISEIZALCO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| EPISEIZALCO | 6.956 [6.12, 7.91] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 1235 out of 2499 males with EPISEIZALCO died.
Mortality risk
Mortality risk for people of age
years, who have EPISEIZALCO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 1.35% | 1.289% |
| 5 | 5.042% | 6.949% |
| 10 | 12.988% | 16.759% |
| 15 | 22.412% | 29.851% |
| 20 | 38.968% | 47.135% |
Relationships between endpoints
↥Index endpoint: EPISEIZALCO – Epileptic seizures related to alcohol
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data